These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586 [TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans]. Ozawa S Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Shimada T; Okuda Y Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745 [TBL] [Abstract][Full Text] [Related]
6. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction. Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839 [TBL] [Abstract][Full Text] [Related]
8. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster. Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323 [TBL] [Abstract][Full Text] [Related]
9. The role of biotransformation in dietary (anti)carcinogenesis. van Iersel ML; Verhagen H; van Bladeren PJ Mutat Res; 1999 Jul; 443(1-2):259-70. PubMed ID: 10415444 [TBL] [Abstract][Full Text] [Related]
10. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042 [TBL] [Abstract][Full Text] [Related]
11. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Butler MA; Guengerich FP; Kadlubar FF Cancer Res; 1989 Jan; 49(1):25-31. PubMed ID: 2908851 [TBL] [Abstract][Full Text] [Related]
12. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver. Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990 [TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Butler MA; Iwasaki M; Guengerich FP; Kadlubar FF Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7696-700. PubMed ID: 2813353 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues. Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798 [TBL] [Abstract][Full Text] [Related]
15. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Shimada T; Yamazaki H; Oda Y; Hiratsuka A; Watabe T; Guengerich FP Chem Res Toxicol; 1996; 9(1):333-40. PubMed ID: 8924613 [TBL] [Abstract][Full Text] [Related]
16. Phase II enzymes and bioactivation. Hinson JA; Forkert PG Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931 [TBL] [Abstract][Full Text] [Related]
17. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009). Yamazaki H; Shimada T Biochem Pharmacol; 1992 Sep; 44(5):913-20. PubMed ID: 1530660 [TBL] [Abstract][Full Text] [Related]
18. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Seaton MJ; Follansbee MH; Bond JA Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens. Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451 [No Abstract] [Full Text] [Related]
20. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man. Mori Y; Konishi Y IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]